デフォルト表紙
市場調査レポート
商品コード
1618683

低侵襲手術市場:タイプ、技術、エンドユーザー別-世界予測2025-2030年

Minimally Invasive Surgery Market by Type (Cardiovascular Surgery, Cosmetic Surgery, Gastrointestinal Surgery), Technology (Endoscopic Surgery, Laparoscopy, Laser & Microsurgery), End Users - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 188 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
低侵襲手術市場:タイプ、技術、エンドユーザー別-世界予測2025-2030年
出版日: 2024年12月01日
発行: 360iResearch
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

低侵襲手術市場は、2023年に719億6,000万米ドルと評価され、2024年には812億1,000万米ドルに達すると予想され、CAGR 13.28%で成長し、2030年には1,723億7,000万米ドルになると予測されています。

低侵襲手術(MIS)には、小切開と腹腔鏡や内視鏡のような高度な器具を利用し、組織外傷を最小限に抑えるように設計された手術手技が含まれます。このアプローチは、入院期間の短縮、回復の早さ、術後の痛みの軽減などの利点から必要とされ、心臓手術から整形外科手術まで、ますます適用範囲が広がっています。最終用途施設には主に病院、専門クリニック、外来手術センターがあり、それぞれがMIS技術の採用拡大に貢献しています。主な成長要因は、手術器具の技術的進歩、外科的介入を必要とする慢性疾患の有病率の増加、患者の嗜好とコスト効率による外来手術の需要の高まりです。ロボット支援システムや拡張現実などの革新的技術のための研究開発投資の増加は、さらに市場拡大に拍車をかけています。新たなビジネスチャンスは、人工知能とデータ分析を統合してMIS手術の精度と治療成績を高めることにあります。しかし、機器の滅菌に関する懸念に加え、初期投資コストの高さや外科専門家の学習曲線の険しさといった課題が、市場成長の潜在的な制約となっています。これらを克服するためには、ハイテク企業とヘルスケアプロバイダーとの戦略的提携がイノベーションを促進し、外科医のトレーニングプログラムを改善することができます。市場が急速に発展する中、研究開発は費用対効果の高い機器の開発や、手技効率を高めるためのリアルタイム画像技術の改良に重点を置くことができます。規制の変化を常に把握し、コンプライアンスを維持することで、技術導入に伴う潜在的なリスクを軽減することもできます。MIS市場は、患者中心の医療へのシフトを反映したダイナミックな市場であり、現在進行中の課題に対処しながら、技術革新と技術進歩への適応が可能なプレーヤーには大きな成長機会がもたらされます。

主な市場の統計
基準年[2023] 719億6,000万米ドル
予測年[2024] 812億1,000万米ドル
予測年[2030] 1,723億7,000万米ドル
CAGR(%) 13.28%

市場力学:急速に進化する低侵襲手術市場の主要市場インサイトを公開

低侵襲手術市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 入院期間の短縮に対する患者の嗜好
    • 世界各地での手術センター、病院、診療所の拡大
    • ヘルスケアサービスの利用しやすさを向上させ、低コストで手術ソリューションを提供するための政府の取り組み
  • 市場抑制要因
    • 手術器具の取り扱いや低侵襲手術の実行の複雑さ
  • 市場機会
    • 先進的な低侵襲手術ソリューションや機器を開発するための継続的な進歩や研究開発。
    • 低侵襲手術機器およびシステムの普及を支える規制当局の承認
  • 市場の課題
    • 感染リスクと手術機器の頻繁なメンテナンスの必要性

ポーターのファイブフォース:低侵襲手術市場をナビゲートする戦略ツール

ポーターのファイブフォース」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:低侵襲手術市場における外部からの影響の把握

外部マクロ環境要因は、低侵襲手術市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析低侵襲手術市場における競合情勢の把握

低侵襲手術市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス低侵襲手術市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、低侵襲手術市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨低侵襲手術市場における成功への道筋を描く

低侵襲手術市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 入院期間の短縮に対する患者の希望
      • 世界中で外科センター、病院、診療所の拡大
      • ヘルスケアサービスのアクセス性を向上させ、より低コストで外科的ソリューションを提供する政府の取り組み
    • 抑制要因
      • 手術器具の取り扱いと低侵襲手術の実施の複雑さ
    • 機会
      • 先進的な低侵襲手術ソリューションと機器を開発するための継続的な進歩と調査イニシアチブ
      • 低侵襲手術機器およびシステムの普及を支援する規制当局の承認
    • 課題
      • 感染のリスクと手術器具の頻繁なメンテナンスの必要性
  • 市場セグメンテーション分析
    • タイプ:整形外科手術に低侵襲手術を採用し、痛みを軽減し、回復を早め、瘢痕を最小限に抑える
    • エンドユーザー:術後即時かつ包括的なケアを提供できるため、世界中の病院で導入が拡大
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 低侵襲手術市場:タイプ別

  • 心臓血管外科
  • 美容整形
  • 消化器外科
  • 婦人科手術
  • 整形外科
  • 泌尿器科手術

第7章 低侵襲手術市場:技術別

  • 内視鏡手術
  • 腹腔鏡検査
  • レーザーとマイクロサージャリー
  • ロボット手術

第8章 低侵襲手術市場:エンドユーザー別

  • 外来手術センター
  • 病院
  • 専門クリニック

第9章 南北アメリカの低侵襲手術市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の低侵襲手術市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの低侵襲手術市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • ストライカー、外反母趾矯正用の先進的なPROstep MIS Lapidusシステムを発表
    • ハンマー趾変形に対する革新的な低侵襲ソリューション:Forma MedicalのOptimalHT
    • オーソフィックス、低侵襲脊椎手術用の強化ナビゲーションシステムを発表
  • 戦略分析と提言

企業一覧

  • Abbott Laboratories
  • Arthrex, Inc.
  • B. Braun SE
  • Boston Scientific Corporation
  • Conmed Corporation
  • Cook Group Incorporated by The Cooper Companies, Inc.
  • Danaher Corporation
  • FUJIFILM Corporation
  • GE HealthCare Technologies Inc.
  • Getinge AB
  • Hoya Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • Karl Storz SE & Co. KG
  • Koninklijke Philips N.V.
  • Livanova PLC
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers
  • Smith & Nephew plc
  • Stryker Corporation
  • Synaptive Medical Inc.
  • Teleflex Incorporated
  • Zimmer Biomet Holdings, Inc.
図表

LIST OF FIGURES

  • FIGURE 1. MINIMALLY INVASIVE SURGERY MARKET RESEARCH PROCESS
  • FIGURE 2. MINIMALLY INVASIVE SURGERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. MINIMALLY INVASIVE SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. MINIMALLY INVASIVE SURGERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MINIMALLY INVASIVE SURGERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MINIMALLY INVASIVE SURGERY MARKET DYNAMICS
  • TABLE 7. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GASTROINTESTINAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY UROLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ENDOSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LASER & MICROSURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 150. MINIMALLY INVASIVE SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. MINIMALLY INVASIVE SURGERY MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-7A22CB0E591C

The Minimally Invasive Surgery Market was valued at USD 71.96 billion in 2023, expected to reach USD 81.21 billion in 2024, and is projected to grow at a CAGR of 13.28%, to USD 172.37 billion by 2030.

Minimally Invasive Surgery (MIS) involves surgical techniques designed to minimize tissue trauma, utilizing small incisions and advanced instruments like laparoscopes and endoscopes. This approach is necessitated by its benefits, including reduced hospital stays, faster recovery, and lesser post-operative pain, making it increasingly applicable in procedures ranging from cardiac to orthopedic surgeries. End-use facilities primarily include hospitals, specialized clinics, and ambulatory surgical centers, each contributing to the growing adoption of MIS technologies. Key growth factors are technological advancements in surgical instruments, an increasing prevalence of chronic diseases necessitating surgical intervention, and heightened demand for outpatient surgeries driven by patient preference and cost-efficiency. Increased investments in R&D for innovative technologies such as robotic-assisted systems and augmented reality further fuel market expansion. Emerging opportunities lie in integrating artificial intelligence and data analytics to enhance precision and outcomes in MIS procedures. However, challenges such as high initial investment costs and a steep learning curve for surgical professionals, in addition to concerns regarding equipment sterilization, are potential limitations to market growth. To overcome these, strategic partnerships between tech companies and healthcare providers can foster innovation and improve training programs for surgeons. As the market rapidly evolves, research can focus on developing cost-effective instruments and improving real-time imaging techniques to enhance procedural efficiency. Keeping abreast of regulatory changes and maintaining compliance can also mitigate the potential risks associated with technology adoption. The MIS market is dynamic, reflecting a shift towards patient-centric care, and presents significant opportunities for growth for players that can innovate and adapt to technological advancements while addressing ongoing challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 71.96 billion
Estimated Year [2024] USD 81.21 billion
Forecast Year [2030] USD 172.37 billion
CAGR (%) 13.28%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Minimally Invasive Surgery Market

The Minimally Invasive Surgery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Patient preference for reducing the duration of hospital stays
    • Expansion of surgical centers, hospitals, and clinics across the world
    • Government initiatives to improve the accessibility of healthcare services and provide surgical solutions at lower cost
  • Market Restraints
    • Complexities of handling surgical equipment and performing minimally invasive surgeries
  • Market Opportunities
    • Ongoing advancements and research initiatives to develop advanced minimally invasive surgical solutions and equipment
    • Regulatory approvals supporting the proliferation of minimally invasive surgical devices and systems
  • Market Challenges
    • Risk of infection and need for frequent maintenance of surgical equipment

Porter's Five Forces: A Strategic Tool for Navigating the Minimally Invasive Surgery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Minimally Invasive Surgery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Minimally Invasive Surgery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Minimally Invasive Surgery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Minimally Invasive Surgery Market

A detailed market share analysis in the Minimally Invasive Surgery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Minimally Invasive Surgery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Minimally Invasive Surgery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Minimally Invasive Surgery Market

A strategic analysis of the Minimally Invasive Surgery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Minimally Invasive Surgery Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Arthrex, Inc., B. Braun SE, Boston Scientific Corporation, Conmed Corporation, Cook Group Incorporated by The Cooper Companies, Inc., Danaher Corporation, FUJIFILM Corporation, GE HealthCare Technologies Inc., Getinge AB, Hoya Corporation, Intuitive Surgical, Inc., Johnson & Johnson Services, Inc., Karl Storz SE & Co. KG, Koninklijke Philips N.V., Livanova PLC, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Siemens Healthineers, Smith & Nephew plc, Stryker Corporation, Synaptive Medical Inc., Teleflex Incorporated, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Minimally Invasive Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Cardiovascular Surgery, Cosmetic Surgery, Gastrointestinal Surgery, Gynecological Surgery, Orthopedic Surgery, and Urological Surgery.
  • Based on Technology, market is studied across Endoscopic Surgery, Laparoscopy, Laser & Microsurgery, and Robotic Surgery.
  • Based on End Users, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Patient preference for reducing the duration of hospital stays
      • 5.1.1.2. Expansion of surgical centers, hospitals, and clinics across the world
      • 5.1.1.3. Government initiatives to improve the accessibility of healthcare services and provide surgical solutions at lower cost
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities of handling surgical equipment and performing minimally invasive surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements and research initiatives to develop advanced minimally invasive surgical solutions and equipment
      • 5.1.3.2. Regulatory approvals supporting the proliferation of minimally invasive surgical devices and systems
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of infection and need for frequent maintenance of surgical equipment
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Adoption of minimally invasive surgeries for orthopedic procedures to ensure less pain, quicker recovery, and minimal scarring
    • 5.2.2. End Users: Expansion of hospitals across the world owing to their capacity to provide immediate, comprehensive post-operative care
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Minimally Invasive Surgery Market, by Type

  • 6.1. Introduction
  • 6.2. Cardiovascular Surgery
  • 6.3. Cosmetic Surgery
  • 6.4. Gastrointestinal Surgery
  • 6.5. Gynecological Surgery
  • 6.6. Orthopedic Surgery
  • 6.7. Urological Surgery

7. Minimally Invasive Surgery Market, by Technology

  • 7.1. Introduction
  • 7.2. Endoscopic Surgery
  • 7.3. Laparoscopy
  • 7.4. Laser & Microsurgery
  • 7.5. Robotic Surgery

8. Minimally Invasive Surgery Market, by End Users

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Minimally Invasive Surgery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Minimally Invasive Surgery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Minimally Invasive Surgery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Stryker Introduces Advanced PROstep MIS Lapidus System for Bunion Correction
    • 12.3.2. Innovative Minimally Invasive Solution for Hammertoe Deformities: Forma Medical's OptimalHT
    • 12.3.3. Orthofix Unveils Enhanced Navigation System for Minimally Invasive Spine Surgery
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Arthrex, Inc.
  • 3. B. Braun SE
  • 4. Boston Scientific Corporation
  • 5. Conmed Corporation
  • 6. Cook Group Incorporated by The Cooper Companies, Inc.
  • 7. Danaher Corporation
  • 8. FUJIFILM Corporation
  • 9. GE HealthCare Technologies Inc.
  • 10. Getinge AB
  • 11. Hoya Corporation
  • 12. Intuitive Surgical, Inc.
  • 13. Johnson & Johnson Services, Inc.
  • 14. Karl Storz SE & Co. KG
  • 15. Koninklijke Philips N.V.
  • 16. Livanova PLC
  • 17. Medtronic plc
  • 18. Olympus Corporation
  • 19. Richard Wolf GmbH
  • 20. Siemens Healthineers
  • 21. Smith & Nephew plc
  • 22. Stryker Corporation
  • 23. Synaptive Medical Inc.
  • 24. Teleflex Incorporated
  • 25. Zimmer Biomet Holdings, Inc.